Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA231991)
Received: 17 September 2020
Accepted: 5 July 2021
First Online: 9 September 2021
Change Date: 29 September 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/S41557-021-00823-X
: B.F.C. is a founder and scientific advisor to Vividion Therapeutics, a biotechnology company interested in developing small-molecule therapeutics.
Free to read: This content has been made available to all.